Your browser doesn't support javascript.
loading
The Coronavirus Pandemic: A Pitfall or a Fast Track for Validating Cell Therapy Products?
Khoury, Maroun; Ikonomou, Laertis; Dominici, Massimo; LeBlanc, Katarina; Levine, Bruce L; Weiss, Daniel J.
Afiliación
  • Khoury M; Laboratory of Nano-Regenerative Medicine, Faculty of Medicine, Universidad de los Andes, Santiago, Chile.
  • Ikonomou L; Cells for Cells and Consorcio Regenero, Chilean Consortium for Regenerative Medicine, Santiago, Chile.
  • Dominici M; Department of Oral Biology, The State University of New York, Buffalo, New York, USA.
  • LeBlanc K; Division of Oncology, Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena, Modena, Italy.
  • Levine BL; Department of Laboratory Medicine, Karolinska Institutet, CAST, Patient Area Cell Therapies and Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, Sweden.
  • Weiss DJ; Center for Cellular Immunotherapies, Department of Pathology and Laboratory Medicine, and Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Stem Cells Dev ; 30(3): 119-127, 2021 02.
Article en En | MEDLINE | ID: mdl-33307968

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pandemias / COVID-19 Aspecto: Ethics Límite: Humans Idioma: En Revista: Stem Cells Dev Asunto de la revista: HEMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Chile Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pandemias / COVID-19 Aspecto: Ethics Límite: Humans Idioma: En Revista: Stem Cells Dev Asunto de la revista: HEMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Chile Pais de publicación: Estados Unidos